Design, Synthesis and Characterization of Covalent KDM5 Inhibitors. Read more about Design, Synthesis and Characterization of Covalent KDM5 Inhibitors.
Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex. Read more about Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.
Allosteric Modulation of Binding Specificity by Alternative Packing of Protein Cores. Read more about Allosteric Modulation of Binding Specificity by Alternative Packing of Protein Cores.
Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia. Read more about Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia.
Guiding COMPASS: Dpy-30 Positions SET1/MLL Epigenetic Signaling. Read more about Guiding COMPASS: Dpy-30 Positions SET1/MLL Epigenetic Signaling.
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy? Read more about Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. Read more about Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies. Read more about Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies.
Furo[3,2-b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway. Read more about Furo[3,2-b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway.
Single-Molecule Protein Phosphorylation and Dephosphorylation by Nanopore Enzymology. Read more about Single-Molecule Protein Phosphorylation and Dephosphorylation by Nanopore Enzymology.
